Kelly McCann

Kelly E. McCann is a board-certified medical oncologist and physician-scientist specializing in breast cancer and translational oncology research. She is a member of the breast cancer care team.

Her clinical and research interests include hormone receptor-positive breast cancer, triple-negative breast cancer, ovarian suppression in premenopausal patients, precision oncology, PARP inhibitors (targeted cancer drugs) and supportive oncology care.

She is nationally recognized for her expertise in breast cancer therapeutics and has served as an invited speaker, moderator and advisor for numerous academic and oncology-focused organizations. Her work focuses on advancing targeted therapies, antibody-drug conjugates, ovarian function suppression strategies and precision medicine approaches for patients with breast cancer.

She currently serves as an associate professor in the Division of Medical Oncology at the UC San Diego School of Medicine. Dr. McCann has served as principal investigator on numerous national and international clinical trials evaluating emerging therapies for breast cancer and solid tumors.

Dr. McCann is deeply committed to medical education and mentorship and has mentored residents, fellows, medical students and undergraduate researchers throughout her academic career. She has received multiple teaching honors, including the UCLA Hematology/Oncology Teacher of the Year Award.